317 filings
Page 9 of 16
8-K
h4k3rkr
5 May 14
Other Events
12:00am
8-K
jno58whn7jm0p 7t
11 Mar 14
Peregrine PHARMACEUTICALS DECLARES QUARTERLY DIVIDEND on ITS Series E Convertible Preferred stock
12:00am
8-K
4vcm3woi03c8a
7 Mar 14
Peregrine Pharmaceuticals Reports THIRD Quarter Fiscal Year 2014 Financial Results and Recent Developments
12:00am
8-K
s7sor zalznvlmbasmo
27 Feb 14
Peregrine Pharmaceuticals Announces Partial Exercise of Overallotment Option In Connection with Preferred Stock Offering
12:00am
8-K
hlq580v9tqgu 25
19 Feb 14
Other Events
12:00am
8-K
228jzdyzlje
12 Feb 14
Entry into a Material Definitive Agreement
12:00am
8-K
y1lmxi8
6 Feb 14
Other Events
12:00am
8-K
fkbl9gg hyy
5 Feb 14
Other Events
12:00am
8-K
092ry
23 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
cby1z
6 Jan 14
Peregrine Pharmaceuticals Receives Fda Fast Track Designation for Its Immunotherapy
12:00am
8-K
qmqr5p
10 Dec 13
Peregrine Pharmaceuticals Reports SECOND Quarter
12:00am
8-K
i3i sxmyo
18 Oct 13
Departure of Directors or Certain Officers
12:00am
8-K
uuhjfd
17 Oct 13
Departure of Directors or Certain Officers
12:00am
8-K
qjeie6wry mh940b8
9 Sep 13
Peregrine Pharmaceuticals Reports First Quarter Fiscal Year 2014 Financial Results and Recent Developments
12:00am
8-K
wohqakh9e
11 Jul 13
Peregrine Pharmaceuticals Reports FOURTH Quarter and Fiscal Year 2013 Financial Results and Recent Developments
12:00am
8-K
60u9 vtfo9b7e1wl
27 Jun 13
Peregrine Pharmaceuticals PROVIDES UPdate on bavituximab clinical program
12:00am
8-K
f5b6oj24
3 Jun 13
Other Events
12:00am
8-K
rs6lzg2rm
20 May 13
Other Events
12:00am
8-K
xg0z5hn3e vt
8 May 13
Departure of Directors or Certain Officers
12:00am
8-K
ydge1my62go4qa0i
12 Mar 13
Peregrine Pharmaceuticals Reports THIRD Quarter Fiscal Year 2013 Financial
12:00am